Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra

Salix and US WorldMeds are zeroing in on doctors, payers and pharmacy shelves as they roll out their opioid withdrawal drug Lucemyra. But it won't be long before marketing expands to a mainstream audience.